319 related articles for article (PubMed ID: 22236028)
1. Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.
Kim H; Kim JJ; Yoon YS
Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):168-78. PubMed ID: 22236028
[TBL] [Abstract][Full Text] [Related]
2. Cell therapy for diabetic neuropathy using adult stem or progenitor cells.
Han JW; Sin MY; Yoon YS
Diabetes Metab J; 2013 Apr; 37(2):91-105. PubMed ID: 23641349
[TBL] [Abstract][Full Text] [Related]
3. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.
Jeong JO; Kim MO; Kim H; Lee MY; Kim SW; Ii M; Lee JU; Lee J; Choi YJ; Cho HJ; Lee N; Silver M; Wecker A; Kim DW; Yoon YS
Circulation; 2009 Feb; 119(5):699-708. PubMed ID: 19171856
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.
Kim H; Park JS; Choi YJ; Kim MO; Huh YH; Kim SW; Han JW; Lee J; Kim S; Houge MA; Ii M; Yoon YS
Stem Cells; 2009 Jul; 27(7):1686-96. PubMed ID: 19544451
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic vasculogenesis using endothelial progenitor cells for treatment of diabetic neuropathies].
Naruse K; Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():622-6. PubMed ID: 15999781
[No Abstract] [Full Text] [Related]
6. Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy.
Kim BJ; Lee JK; Schuchman EH; Jin HK; Bae JS
Cell Tissue Res; 2013 Nov; 354(2):395-407. PubMed ID: 23942895
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-colony stimulating factor as a treatment for diabetic neuropathy in rat.
Kim KS; Song YS; Jin J; Joe JH; So BI; Park JY; Fang CH; Kim MJ; Cho YH; Hwang S; Ro YS; Kim H; Ahn YH; Sung HJ; Sung JJ; Park SH; Lipton SA
Mol Cell Endocrinol; 2015 Oct; 414():64-72. PubMed ID: 26190836
[TBL] [Abstract][Full Text] [Related]
8. The neuro-restorative effect of adipose-derived mesenchymal stem cell transplantation on a mouse model of diabetic neuropathy.
Yigitturk G; Erbas O; Karabay Yavasoglu NU; Acikgoz E; Buhur A; Gokhan A; Gurel C; Gunduz C; Yavasoglu A
Neurol Res; 2022 Feb; 44(2):156-164. PubMed ID: 34410214
[TBL] [Abstract][Full Text] [Related]
9. Autologous Bone Marrow-Derived Stem Cells for Treating Diabetic Neuropathy in Metabolic Syndrome.
Liu W; Yu F; Zhou Z; Li YC; Fan D; Zhu K
Biomed Res Int; 2017; 2017():8945310. PubMed ID: 29098161
[TBL] [Abstract][Full Text] [Related]
10. Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box?
Liew A; McDermott JH; Barry F; O'Brien T
Diabetes Obes Metab; 2008 May; 10(5):353-66. PubMed ID: 17825082
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy.
Naruse K; Hamada Y; Nakashima E; Kato K; Mizubayashi R; Kamiya H; Yuzawa Y; Matsuo S; Murohara T; Matsubara T; Oiso Y; Nakamura J
Diabetes; 2005 Jun; 54(6):1823-8. PubMed ID: 15919805
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic.
Zhou JY; Zhang Z; Qian GS
Cell Death Discov; 2016; 2():16055. PubMed ID: 27551543
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy.
Naruse K; Sato J; Funakubo M; Hata M; Nakamura N; Kobayashi Y; Kamiya H; Shibata T; Kondo M; Himeno T; Matsubara T; Oiso Y; Nakamura J
PLoS One; 2011; 6(11):e27458. PubMed ID: 22125614
[TBL] [Abstract][Full Text] [Related]
14. Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy.
Oses C; Olivares B; Ezquer M; Acosta C; Bosch P; Donoso M; Léniz P; Ezquer F
PLoS One; 2017; 12(5):e0178011. PubMed ID: 28542352
[TBL] [Abstract][Full Text] [Related]
15. The promise of EPC-based therapies on vascular dysfunction in diabetes.
Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D
Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073
[TBL] [Abstract][Full Text] [Related]
16. Update on the pathogenesis of diabetic neuropathy.
Obrosova IG
Curr Diab Rep; 2003 Dec; 3(6):439-45. PubMed ID: 14611738
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for diabetic neuropathy.
Tahrani AA; Askwith T; Stevens MJ
Expert Opin Emerg Drugs; 2010 Dec; 15(4):661-83. PubMed ID: 20795891
[TBL] [Abstract][Full Text] [Related]
18. [Nerve growth factor and diabetic neuropathy].
Castellano O; Martínez-Martí L; Gómez-Fernández L
Rev Neurol; 1998 Jun; 26(154):1032-9. PubMed ID: 9658489
[TBL] [Abstract][Full Text] [Related]
19. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.
Huang PH; Chen JW; Lin CP; Chen YH; Wang CH; Leu HB; Lin SJ
Cardiovasc Diabetol; 2012 Aug; 11():99. PubMed ID: 22894755
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration.
Veves A; Akbari CM; Primavera J; Donaghue VM; Zacharoulis D; Chrzan JS; DeGirolami U; LoGerfo FW; Freeman R
Diabetes; 1998 Mar; 47(3):457-63. PubMed ID: 9519754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
